• E-mail
• Print
• RSS

Medicare identifies priciest drugs

Case Management Insider, January 12, 2016

A new analysis by the Centers for Medicare and Medicaid Services has found only 40 medications resulted in nearly three-quarters of physician and outpatient drug spending last year.

“The top Part D drugs with highest total spending were Abilify, Advair Diskus, Crestor, Nexium, and Sovaldi,” stated Medicare in a written release. “The top five Part B drugs with highest total spending were aflibercept, ranibizumab, pegfilgrastim, imfliximab, and rituximab. Each of these drugs contributed more than $1 billion in spending for the Medicare Part B program.”

Each of the Part D drugs had total drug spending of more than $2 billion in 2014, except Sovaldi, which was introduced in 2013. Similarly, the Part B drugs contributed to more than $1 billion in spending.

• E-mail to a Colleague
• Print
• RSS
• Archive